Reference
Institute for Safe Medication Practices. Pimavanserin (NUPLAZID) and Hallucinations. ISMP QuarterWatch : 7-11, 1 Nov 2017. Available from: URL: http://www.ismp.org/quarterwatch/pdfs/2017Q1.pdf
Rights and permissions
About this article
Cite this article
Pimavanserin: seeking approval for larger patient populations. Reactions Weekly 1678, 9 (2017). https://doi.org/10.1007/s40278-017-38555-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-38555-z